Missouri Patients Gain Virtual Lifeline for Rheumatology Care
- 70-day wait for new rheumatology appointments in Missouri, reduced to within 10 business days via virtual consultations
- 1 rheumatologist per 41,000 residents in Missouri (2022 data)
- 2023 systematic review: 18 out of 20 tele-rheumatology studies showed positive results, all cost analyses indicated cost-effectiveness
Experts agree that virtual rheumatology care significantly improves access, reduces wait times, and offers cost-effective, high-quality outcomes comparable to in-person visits.
Missouri Patients Gain Virtual Lifeline for Rheumatology Care
COLUMBIA, MO β April 22, 2026 β Patients in Missouri facing debilitating waits for specialized medical care have been offered a new lifeline. Columbia Orthopaedic Group, a cornerstone of musculoskeletal care in the state for over 60 years, has announced a landmark partnership with Remission Medical, a national virtual rheumatology practice. The collaboration aims to dismantle the long-standing barriers to accessing rheumatology specialists, leveraging technology to provide swift diagnosis and treatment for thousands of residents.
For Missourians suffering from conditions like arthritis, lupus, and gout, the journey to see a specialist has been a test of endurance. New patients often wait over 70 days for an appointment, a critical delay when dealing with progressive autoimmune and inflammatory diseases. This partnership promises to slash that wait time, offering virtual consultations within days rather than months.
"We see first-hand the challenges our patients face in seeking rheumatology care," said Andrew Lovewell, CEO of Columbia Orthopaedic Group, in a statement. "The problem is not only a matter of wait times, but of disease progression. We saw the opportunity to offer better options that align with our mission through our partnership with Remission. Now we can enable patients to more quickly receive a diagnosis and begin therapy, if needed."
A Statewide Crisis Meets a Digital Solution
The need for this intervention is stark. According to the American College of Rheumatology (ACR), Missouri had just one rheumatologist for every 41,000 residents in 2022, a ratio that forces many to endure pain and uncertainty while their conditions may worsen. With over a quarter of all U.S. adults living with a rheumatic condition, according to the CDC, the shortage represents a significant public health challenge. The state's large rural population, spread across 97% of its landmass, further complicates access to centralized medical specialists.
Remission Medical enters this landscape as a digital-first provider, built to bridge these exact gaps. The company utilizes a proprietary platform for secure video visits with board-certified, state-licensed rheumatology clinicians. This model bypasses the geographical and logistical hurdles that prevent patients from receiving timely care. Research supports this approach, with studies showing that telehealth can be highly effective for rheumatology, offering comparable outcomes to in-person follow-ups and high levels of patient satisfaction.
One 2023 systematic review of 20 tele-rheumatology studies found positive results in 18 of them, with all cost analyses indicating cost-effectiveness. Patients frequently cite the convenience of avoiding travel, reducing time off work, and the comfort of being seen from their own homes as major benefits. Remission Medical's promise of appointments within 10 business days stands in sharp contrast to the multi-month standard, offering immediate relief and a path forward for suffering patients.
The Future of Integrated Specialty Care
This partnership is more than just an access solution; it represents a strategic evolution in how comprehensive musculoskeletal care is delivered. By integrating virtual rheumatology, Columbia Orthopaedic Group is expanding its services beyond traditional orthopaedics, which typically focuses on the surgical and mechanical aspects of bone and joint health. This move acknowledges the deep connection between orthopaedic and rheumatologic conditions, creating a more holistic and patient-centered care continuum.
Patients with joint pain may be unsure if their issue is mechanical (orthopaedic) or inflammatory (rheumatologic). By housing both specialties under one umbrella, the group can more effectively triage patients and ensure they receive the correct diagnosis and treatment plan without being referred out to a system with prohibitive wait times.
"Columbia Orthopaedic Group and their leadership continue to innovate and find ways to support patients in their community," commented Blake Wehman, CEO and Founder of Remission Medical. Wehman founded the company with a personal connection to its mission, having managed a rheumatic condition himself. "We're honored to support their steadfast mission to care for their patients and provide excellence in surgical and non-surgical care."
A Model for an Evolving Healthcare System
The collaboration operates within a supportive regulatory framework. Missouri state law has embraced telehealth, permitting licensed healthcare providers to deliver services virtually, provided they adhere to the same standard of care as in-person visits. This has paved the way for innovative models like the one being pioneered by Columbia Orthopaedic Group and Remission Medical. While clinicians must be licensed in Missouri to treat its residents, Remission Medical's national network is structured to meet these state-by-state requirements.
As the demand for specialists continues to outpace supply nationwideβwith the ACR projecting a shortage of over 4,000 rheumatologists by 2030βhybrid models that combine the strengths of established local practices with the reach of virtual specialty platforms are becoming increasingly vital. This partnership not only provides a desperately needed service to the people of Missouri but also serves as a blueprint for how healthcare systems across the country can overcome specialist shortages, improve patient outcomes, and build a more resilient and accessible system of care.
π This article is still being updated
Are you a relevant expert who could contribute your opinion or insights to this article? We'd love to hear from you. We will give you full credit for your contribution.
Contribute Your Expertise β